[Image courtesy of Ypsomed and S3 Connected Health]
Ypsomed announced plans to expand its offerings of digital health solutions for chronic disease therapy together with S3 Connected Health.
Dublin, Ireland-based S3 Connected Health specializes as a digital health partner for life science companies. This partnership allows Ypsomed’s biopharma customers to quickly launch therapy-specific digital patient solutions. It enables therapy management support for acute and chronic diseases while enhancing outcomes.
Ypsomed said in a news release that the companies aim to create an extendable platform to create specific solutions. These offerings provide patients with support and guidance throughout therapy. Ypsomed’s connected injection devices, including the SmartPilot for YpsoMate, come pre-integrated into the platform.
The platform itself offers versatility and customization capabilities for any disease area and use case, the companies say.
Get the full story at our sister site, Drug Delivery Business News.
